Quality-adjusted life year (QALY) · spine care

Quality-Adjusted Life Years: Measuring What Spine Care Returns

A quality-adjusted life year counts a year in full health as one and a year at half of full health as half, and spine trials use it to express what an intervention returns. Applied to a referral, it only means something when a baseline health utility score is recorded before the referral.

Every spine trial that reports value reports it in years of health. Few referral letters record the baseline those years are counted from, or the metabolic terrain that decides whether they accrue.

The quality-adjusted life year (QALY) is the unit most spine trials use to express what an intervention returns: a year in full health counts as one, and a year at half of full health counts as half. It is usually quoted in policy work, but underneath it sits a clinical measurement, the health utility score, and that score is rarely recorded before a referral. The video for Chapter 18 of The Pained Brain, by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Dr. KrisJay Fucanan, MD, works through the spine evidence in those units; study-level detail and limits are in the Chapter 18 book companion. Here the unit is treated as what it is for the ordering physician: an outcome measure, with a baseline, a horizon and blind spots.

What is the health utility score inside a QALY?

US population norms place mean utility at 0.824 for adults aged 65 to 74. A Danish national catalog put dorsalgia at 0.619 and fibromyalgia at 0.490, lower than dementia at 0.546, and listed both among the conditions with the largest modeled loss of quality of life. Among 1,194 patients scheduled for degenerative lumbar spine surgery in Singapore, mean preoperative utility was 0.43, with 93.6 percent reporting pain or discomfort. Chronic pain removes a third to a half of a year of health from each year lived with it.

The instrument has a known weakness: the value set changes the number. Among 34,254 Swedish osteoarthritis patients, the same people scored 0.792 on a Swedish experience-based value set and 0.605 on a UK hypothetical one. Utilities borrowed across countries are unreliable. Recorded in one practice, with one instrument, repeated over time, they become a usable longitudinal outcome.

Why does the starting utility score decide the benefit?

The clearest evidence that starting utility predicts surgical return comes from arthroplasty. In a German multicenter study of 4,182 hip and 3,645 knee replacements, the minimal clinically important change in utility was 0.2, and patients starting above 0.7 for a hip or 0.6 for a knee gained no meaningful benefit. Those thresholds are decision aids from joint surgery, not spine rules, but the principle transfers: an operation cannot restore utility a patient has not lost. Decision support changes real choices, too. When a large health system introduced decision aids for hip and knee osteoarthritis, hip replacements fell 26 percent and knee replacements 38 percent. Neither finding can be applied to an individual unless a baseline exists in the chart before the referral.

What do spine trials show when patients are followed longer?

Two-year spine outcomes and eight-year outcomes are different findings. In the SPORT stenosis cohort, the surgical advantage in years three and four was reduced by approximately 75 percent from the first two years, and no significant effect of surgery remained in years six through eight. By then, 70 percent randomized to surgery and 52 percent randomized to non-operative care had been operated on, which dilutes intention-to-treat contrasts in both directions. The spondylolisthesis cohort analyzed as treated, by contrast, kept its surgical advantage at eight years.

The fusion question is where the unit is most informative. At two years, adding fusion to a stenosis decompression added −0.01 quality-adjusted life years. For chronic low back pain without a slip, fusion against intensive rehabilitation produced a 0.068 difference that was not significant, and at eleven years the fusion advantage on a 100-point disability scale was −0.7 points. Pooled, fusion for degenerative disc disease carried 21.46 times the complication rate of non-operative care. Randomized trials in Sweden and Norway found decompression alone comparable or non-inferior; an American trial reported a reoperation rate of 14 percent with fusion versus 34 percent without.

What can a QALY miss?

A utility score can miss a real clinical gain. In 325 older adults with insomnia and osteoarthritis pain, six telephone sessions of cognitive behavioral therapy lowered insomnia severity and joint symptoms by 2.6 points each and added 89 nights without insomnia over twelve months, yet the utility difference was −0.01. Lifetime gains are also often projected rather than measured: the 0.06 quality-adjusted life years in the British diabetes remission trial were driven by modeled life expectancy, not measured two-year utility. The practical conclusion is to pair utility with measures that move faster and are harder to dispute, namely function, body composition, metabolic markers and cognition.

Terrain as a measurable predictor

The patient at the center of the video had a lumbar MRI in the second week of her pain and no hemoglobin A1c in four years. When it was drawn, it was 6.4. In a series of 678 posterolateral fusions for degenerative spondylolisthesis, age did not remain a significant predictor of medical complications after adjustment, while anesthesia risk score and body mass index did. The lifestyle arm of the Diabetes Prevention Program cut diabetes incidence by 34 percent, and in knee osteoarthritis with class III obesity, a modeled gastric bypass strategy lowered opioid use from 13 to 4 percent. Those are two biological drivers, insulin resistance and adipose mass, plus a structural one: care pathways that begin with an image or an opioid. In a veterans cohort, an opioid as the opening treatment in place of physical therapy was associated with 1.69-fold odds of spine surgery inside one year and 17.8 times the odds of chronic opioid use. The book is candid that early conservative care is not a guaranteed win; in the randomized trial, the early physical therapy benefit stayed below the threshold of clinical importance.

Measura [Cardiometabolic and Autonomic Health Analysis] is a testing service; it does not read imaging or recommend surgery. For a patient headed toward a spine referral it documents:

• Metabolic status through laboratory panels, including glucose and insulin markers.
• Body composition through bioimpedance body composition, replacing body mass index with measured fat and lean compartments.
• Cognition through a cognitive assessment in older candidates, with fall-prevention screening paired in the same visit.

Workflow: blood before the scan

The sequence the book argues for is blood before scan, block before burn, bridge before fusion, with named exceptions: cauda equina syndrome is decompressed within 48 hours, and a herniated disc that has failed everything goes to the surgeon promptly. For the rest, a standing order can attach metabolic labs, body composition and a baseline utility instrument to new chronic back pain referrals before advanced imaging, so the first data point is the terrain. The annual wellness visit is a natural home for that baseline in older patients, and filing results as discrete data keeps them visible when the surgical consult returns. How a dose total displaced the patient in pain care is examined in morphine milligram equivalents as a risk variable.

Frequently asked questions

References

• Jiang, R., Janssen, M. F. B., & Pickard, A. S. (2021). US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples. Quality of Life Research, 30(3), 803–816. https://doi.org/10.1007/s11136-020-02650-y
• Hvidberg, M. F., Petersen, K. D., Davidsen, M., Witt Udsen, F., Frølich, A., Ehlers, L., & Alava, M. H. (2023). Catalog of EQ-5D-3L Health-Related Quality-of-Life Scores for 199 Chronic Conditions and Health Risks in Denmark. MDM Policy & Practice, 8(1), 23814683231159023. https://doi.org/10.1177/23814683231159023
• Li, X., Chern, C. W. J., Teo, A. Q. A., Tan, J. H. J., Vasan Thakumar, A., Luo, N., Hey, H. W. D., & Cheng, L. J. (2026). Factors associated with preoperative health-related quality of life in patients undergoing lumbar spine surgery: a multi-ethnic Asian cohort. Quality of Life Research, 35(6). https://doi.org/10.1007/s11136-026-04257-1
• Langenberger, B., Steinbeck, V., & Busse, R. (2024). Who Benefits From Hip Arthroplasty or Knee Arthroplasty? Preoperative Patient-reported Outcome Thresholds Predict Meaningful Improvement. Clinical Orthopaedics and Related Research, 482(5), 867–881. https://doi.org/10.1097/CORR.0000000000002994
• Tosteson, A. N. A., Tosteson, T. D., Lurie, J. D., Abdu, W., Herkowitz, H., Andersson, G., Albert, T., Bridwell, K., Zhao, W., Grove, M. R., Weinstein, M. C., & Weinstein, J. N. (2011). Comparative effectiveness evidence from the spine patient outcomes research trial: surgical versus nonoperative care for spinal stenosis, degenerative spondylolisthesis, and intervertebral disc herniation. Spine, 36(24), 2061–2068. https://doi.org/10.1097/BRS.0b013e318235457b
• Lurie, J. D., Tosteson, T. D., Tosteson, A., Abdu, W. A., Zhao, W., Morgan, T. S., & Weinstein, J. N. (2015). Long-term outcomes of lumbar spinal stenosis: eight-year results of the Spine Patient Outcomes Research Trial (SPORT). Spine, 40(2), 63–76. https://doi.org/10.1097/BRS.0000000000000731
• Rivero-Arias, O., Campbell, H., Gray, A., Fairbank, J., Frost, H., & Wilson-MacDonald, J. (2005). Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial. BMJ, 330(7502), 1239. https://doi.org/10.1136/bmj.38441.429618.8F
• Yeung, K., Zhu, W., McCurry, S. M., Von Korff, M., Wellman, R., Morin, C. M., & Vitiello, M. V. (2022). Cost-effectiveness of telephone cognitive behavioral therapy for osteoarthritis-related insomnia. Journal of the American Geriatrics Society, 70(1), 188–199. https://doi.org/10.1111/jgs.17469
• Aimar, E., Iess, G., Mezza, F., Gaetani, P., Messina, A. L., Todesca, A., Tartara, F., & Broggi, G. (2022). Complications of degenerative lumbar spondylolisthesis and stenosis surgery in patients over 80 s: comparative study with over 60 s and 70 s. Experience with 678 cases. Acta Neurochir (Wien), 164(3), 923-931. https://doi.org/10.1007/s00701-022-05118-9
• Schmidt, C., Borgia, M., Zhang, T., Gochyyev, P., Shireman, T. I., & Resnik, L. (2023). Initial treatment approaches and healthcare utilization among veterans with low back pain: a propensity score analysis. BMC Health Serv Res, 23(1), 275. https://doi.org/10.1186/s12913-023-09207-y

Related reading

• Morphine Milligram Equivalents Are Not a Risk Assessment
• Comprehensive Pain Assessment: Measuring What the Short Visit Skips
• Laboratory Panels

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed September 12, 2026.